Kolexia
Bibeau Frédéric
Anatomie et cytologie
Hôpital Jean-Minjoz
Besançon, France
247 Activités
18 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Adénocarcinome Tumeurs du sein Tumeurs du côlon Carcinomes Tumeurs du rectum Tumeurs du péritoine Instabilité des microsatellites

Industries

MSD
50 collaboration(s)
Dernière en 2023
CanceroDigest
18 collaboration(s)
Dernière en 2023
BMS
9 collaboration(s)
Dernière en 2023
Astellas
8 collaboration(s)
Dernière en 2023

Dernières activités

Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 février 2024
Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott).
Journal of medical virology   08 février 2024
CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy.
Oncoimmunology   21 décembre 2023
BIG-RENAPE: Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies
Essai Clinique (Hospices Civils de Lyon)   19 décembre 2023
Evaluation of immune infiltrate according to the HER2 status in colorectal cancer.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 octobre 2023
1642P Prognostic impact of an immunomorphological signature integrating immune, fibroblastic and tumor markers in a series of 217 resected pancreatic adenocarcinoma patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
IDEA: A Phase III Randomized Trial Investigating the Duration of Adjuvant Therapy(3 Versus 6 Months) With the Modified FOLFOX 6 or XELOX Regimens for Patients With Stage III Colon Cancer
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   27 septembre 2023
Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells.
Oncogene   26 août 2023
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer.
EBioMedicine   25 mai 2023
EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.
Oncogene   05 mai 2023